Deferiprone
Showing 1 - 25 of 74
Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)
No longer available
- Pantothenate Kinase-Associated Neurodegeneration
- Deferiprone
- (no location specified)
Nov 9, 2022
Acute Myocardial Infarction Type 1 Trial in Indianapolis (Deferiprone Tablets, Placebo)
Recruiting
- Acute Myocardial Infarction Type 1
- Deferiprone Tablets
- Placebo
-
Indianapolis, IndianaKrannert Cardiovascular Research Center
Dec 14, 2022
SAH, Dementia Trial in Iowa City (Deferiprone pill, , Montreal Cognitive Assessment)
Recruiting
- SAH
- Dementia
- Deferiprone pill
- +2 more
-
Iowa City, IowaUnivesity of Iowa Hospital and Clinics
Mar 7, 2022
Aceruloplasminemia Trial in Fuzhou (Deferiprone treated)
Recruiting
- Aceruloplasminemia
- Deferiprone treated
-
Fuzhou, Fujian, ChinaDepartment of Neurology , First Affiliated Hospital Fujian Medic
Nov 21, 2021
Mild Cognitive Impairment, Prodromal Alzheimer's Disease, Mild Alzheimer's Disease Trial in Australia (Deferiprone 600mg delayed
Active, not recruiting
- Mild Cognitive Impairment
- +2 more
- Deferiprone 600mg delayed release tablets
- Placebo Oral Tablet
-
Macquarie Park, New South Wales, Australia
- +7 more
Mar 8, 2022
Amyotrophic Lateral Sclerosis Trial in France (Deferiprone, Placebo Oral Tablet)
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Deferiprone
- Placebo Oral Tablet
-
Angers, France
- +14 more
Nov 4, 2022
Stroke Trial in Bordeaux, Lille, Montpellier (Magnetic Resonance Imaging (MRI), Deferiprone treatment)
Recruiting
- Stroke
- Magnetic Resonance Imaging (MRI)
- Deferiprone treatment
-
Bordeaux, France
- +2 more
Jun 9, 2022
Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (Deferiprone DR tablets 1000 mg (Low dosage),
Completed
- Iron Overload Due to Repeated Red Blood Cell Transfusions
- Deferiprone DR tablets 1000 mg (Low dosage)
- Deferiprone DR tablets 1000 mg (High dosage)
-
Chicago, Illinois
- +4 more
Jun 17, 2021
Beta Thalassemia Major Anemia, Iron Overload Trial in Cairo, Jakarta (Deferiprone oral solution, Placebo)
Completed
- Beta Thalassemia Major Anemia
- Iron Overload
- Deferiprone oral solution
- Placebo
-
Cairo, Egypt
- +3 more
Feb 9, 2021
Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)
Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution)
Completed
- Pantothenate Kinase-Associated Neurodegeneration
- Deferiprone oral solution
-
Oakland, California
- +3 more
Aug 12, 2020
Parkinson's Disease Trial in London (Deferiprone 20mg, Placebo, Deferiprone 30mg)
Completed
- Parkinson's Disease
- Deferiprone 20mg
- +2 more
-
London, United KingdomCentre for Neuroscience, Imperial College London
Jun 3, 2020
Acute Kidney Injury Trial (deferiprone, Placebo)
Withdrawn
- Acute Kidney Injury
- deferiprone
- Placebo
- (no location specified)
Aug 20, 2020
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)
Parkinson Disease Trial in Worldwide (Deferiprone, Placebo)
Active, not recruiting
- Parkinson Disease
- Deferiprone
- Placebo
-
Innsbruck, Austria
- +24 more
Mar 9, 2021
Parkinson's Disease, Amyotrophic Lateral Sclerosis, Oxidative Stress Trial in Lille (deferiprone, )
Completed
- Parkinson's Disease
- +3 more
- deferiprone
- placebo
-
Lille, FranceHôpital Roger Salengro, CHRU de Lille
Mar 25, 2020
Deferiprone (Ferriprox®) in Treatment of Superficial Siderosis
Completed
- Superficial Siderosis
-
Baltimore, MarylandJohns Hopkins University
Aug 26, 2019
Parkinson's Disease Trial in Worldwide (Deferiprone, Placebo)
Completed
- Parkinson's Disease
- Deferiprone
- Placebo
-
Toronto, Ontario, Canada
- +19 more
Nov 14, 2019
Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution, Placebo)
Completed
- Pantothenate Kinase-Associated Neurodegeneration
- Deferiprone oral solution
- Placebo
-
Oakland, California
- +3 more
Jun 27, 2019
Thalassemia Major With Severe Transfusional Iron Overload Trial in Chicago, Philadelphia (Deferasirox and deferiprone)
Completed
- Thalassemia Major With Severe Transfusional Iron Overload
- Deferasirox and deferiprone
-
Chicago, Illinois
- +1 more
Feb 13, 2019
Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)
Completed
- Thalassemia, Beta
- Hydroxyurea and Thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 23, 2023
Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer
Completed
- Myelodysplastic Syndrome With Low-grade Lesions
- Iron Overload Due to Repeated Red Blood Cell Transfusions
- Deferiprone
-
Tel Hashomer, IsraelChim Sheba Medical Center
Oct 30, 2018
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone)
Unknown status
- Iron Overload
- +2 more
- Deferiprone
-
Oakland, California
- +12 more
Jan 10, 2019